Topics covered in this episode include: - Amicus Therapeutics' (FOLD) Galafold updated submission guidance from the FDA (0:48)
- Novartis (NVS) CAR-T ad-comm meeting results (6:30)
- Round table quick takes (13:34):
- Array (ARRY) submits two NDAs for binimetinib and encorafenib
- Tesaro (TSRO)- still a buyout candidate?
- Rumors AstraZeneca (AZN) CEO on the move to Teva (TEVA)
Click here to view: https://soundcloud.com/dmhcap/7142017a
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: